Profile
Michael G.
Wokasch was Chief Operating Officer of Oculus Innovative Sciences, Inc. from June 2006 to September 2008.
He was Senior Vice President-Global Commercial Operations of the biopharmaceuticals division of Chiron Corporation from July 2004 to June 2006 and Chief Operating Officer of Impax Laboratories, Inc. from January 2003 to June 2004.
Mr. Wokasch was President of Aurora Biosciences Corporation and PanVera Corporation from July 2001 to December 2002 and President and Chief Executive Officer of Gala Design, Inc. from June 2000 to July 2001.
He received a BS from the University of Minnesota, College of Pharmacy.
Former positions of Michael G. Wokasch
| Companies | Position | End |
|---|---|---|
| SONOMA PHARMACEUTICALS, INC. | Chief Operating Officer | 05/09/2008 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | 01/06/2006 |
Impax Laboratories LLC
 Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Chief Operating Officer | 01/06/2004 |
Pan Vera LLC
 Pan Vera LLC BiotechnologyHealth Technology PanVera LLC develops protein drug targets and drug screening assays for high throughput screening. The company is headquartered in Madison, WI. | President | 01/12/2002 |
Gala Biotech
 Gala Biotech Pharmaceuticals: MajorHealth Technology Part of Cardinal Health, Inc., Gala Biotech develops gene insertion technology to produce pharmaceutical proteins. The company is based in Middleton, WI. Gala Biotech was acquired by Cardinal Health, Inc. on October 01, 2003 for $15.50 million. | President | 01/07/2001 |
Training of Michael G. Wokasch
| University of Minnesota | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SONOMA PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Impax Laboratories LLC
Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Health Technology |
Aurora Biosciences Corp.
 Aurora Biosciences Corp. BiotechnologyHealth Technology Aurora Biosciences Corp. designs and develops proprietary drug discovery systems, services and technologies to the discovery of new medicine. It develops a proprietary ultra-high throughput screening platform that uniquely integrates innovative fluorescence chemistry, molecular biology, miniaturization, automation, and informatics. The company also provides assay development and screening services. Aurora was founded in 1995 and is located in San Diego, CA. | Health Technology |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Pan Vera LLC
Pan Vera LLC BiotechnologyHealth Technology PanVera LLC develops protein drug targets and drug screening assays for high throughput screening. The company is headquartered in Madison, WI. | Health Technology |
Gala Biotech
Gala Biotech Pharmaceuticals: MajorHealth Technology Part of Cardinal Health, Inc., Gala Biotech develops gene insertion technology to produce pharmaceutical proteins. The company is based in Middleton, WI. Gala Biotech was acquired by Cardinal Health, Inc. on October 01, 2003 for $15.50 million. | Health Technology |
- Stock Market
- Insiders
- Michael G. Wokasch
